Assignee
PARACRINE THERAPEUTICS AB
SE·2 granted patents·2 pending applications·0 citations·filing 2016–2023
Top patents by PatentIndex Score
4 records- 0160US2022275075A1Methods and compositions for pdgf-cc inhibitionPARACRINE THERAPEUTICS AB·Filed 2022·Application pending·0 cites
- 0260US2023310385A1Treatment of er-negative breast cancer with an pdgf-cc inhibitor and an anti-estrogenPARACRINE THERAPEUTICS AB·Filed 2023·Application pending·0 cites
- 0350US11633382B2Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and anti-estrogenPARACRINE THERAPEUTICS AB·Filed 2016·Granted Apr 25, 2023·0 cites·6 claims
- 0450US11352420B2Methods and compositions for PDGF-CC inhibitionPARACRINE THERAPEUTICS AB·Filed 2017·Granted Jun 7, 2022·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when PARACRINE THERAPEUTICS AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →